7MW4911

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 7MW4911, covering 2025-12-29 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of 7MW4911 in GI Cancer [Phase 1, Phase 2]